Get started
Award

441891347

Funded outputs count: 22
Funder award ID: 441891347
OpenAlex ID: G5701955240
Extracorporeal photopheresis for the treatment of steroid-refractory immune related adverse events from immune checkpoint inhibitor therapy: a multi-center phase Ib/II clinical trial
2026 · Roxane Riemer, Lukas M. Braun, et al. · Nature Communications
PDF
Characterisation of TP53 mutational features and outcomes of acute myeloid leukaemia after allogeneic haematopoietic cell transplantation
2026 · Martina Reuss, Thomas Meyer, et al. · Bone Marrow Transplantation
PDF
Improvement of Gemcitabine Treatment of Pancreatic Cancer by the Addition of All- trans Retinoic Acid and Identification of Vitamin A and Pentraxin 3 as Potential Response Biomarkers
2026 · Sarah Niessen, Carola Focke, et al. · medRxiv
PDF
Pegtarazimod limits acute graft-versus-host disease mortality and severity in mice and is tolerated in patients
2026 · Verena Holzmüller, Jana Gawron, et al. · Journal of Clinical Investigation
PDF
Lipid signatures in two functionally selected effluents from clinically relevant postoperative pancreatic fistulas are associated with graded, cell type–specific transcriptional responses
2026 · Johannes D. Lettner, Marvin Schwarzer, et al. · Scientific Reports
PDF
Necroptosis triggers inflammatory interferon signatures in patient-derived metastatic breast cancer organoids
2026 · Kaja Nicole Wächtershäuser, Jana V. Schneider, et al. · Signal Transduction and Targeted Therapy
PDF
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations
2026 · Philipp Hafner, Steffen J. Keller, et al. · Signal Transduction and Targeted Therapy · 9
PDF
Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies
2025 · Michael Rassner, Tony Andreas Müller, et al. · Signal Transduction and Targeted Therapy · 1
PDF
Saturation mutagenesis identifies activating and resistance-inducing FGFR kinase domain mutations
2025 · Carla Tangermann, Avantika Ghosh, et al. · Nature Genetics · 8
PDF
Effect of the mitophagy inducer urolithin A on age-related immune decline: a randomized, placebo-controlled trial
2025 · Dominic Denk, Anurag Singh, et al. · Nature Aging · 50
PDF
Common Practice of Percutaneous Drainage in Necrotising Pancreatitis—A Multicentre Retrospective Study (DRACULA)
2025 · Marlies Vornhülz, Simon Sirtl, et al. · United European Gastroenterology Journal · 3
PDF
Adaptive resistance to SHP2-based vertical RAS-pathway inhibition in pancreatic cancer involves multifaceted routes towards dedifferentiation
2025 · Xun Chen, Steffen Johannes Keller, et al. · medRxiv
PDF
Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines
2024 · Daniela Kocher, Lei Cao, et al. · Journal of Neuro-Oncology · 14
PDF
Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia
2024 · Florian Märkl, Christoph Schultheiß, et al. · Nature Communications · 15
PDF
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
2023 · Elena Kotsiliti, Valentina Leone, et al. · Journal of Hepatology · 109
PDF
Integrated Metabolomic and Transcriptomic Analysis of Modified Nucleosides for Biomarker Discovery in Clear Cell Renal Cell Carcinoma
2023 · Daniel A. Mohl, Simon Lagies, et al. · Cells · 12
PDF
Species-specific LUBAC-mediated M1 ubiquitination regulates necroptosis by segregating the cellular distribution and fate of activated MLKL
2022 · Nadine Weinelt, Kaja Nicole Wächtershäuser, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment
2022 · Asmaa Elrakaybi, Dietrich A. Ruess, et al. · Cancers · 22
PDF
The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
2022 · Jens Bauer, Natalie Köhler, et al. · Nature Communications · 78
PDF
USP22 controls type III interferon signaling and SARS-CoV-2 infection through activation of STING
2022 · Rebekka Karlowitz, Megan L. Stanifer, et al. · Cell Death and Disease · 28
PDF
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
2022 · Francesca Biavasco, Gabriele Ihorst, et al. · Bone Marrow Transplantation · 33
PDF
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
2021 · Nadia El Khawanky, Amy Hughes, et al. · Nature Communications · 109
PDF
Year
Topic